Emerging pharmacological strategies in the fight against cocaine addiction (Q36407408)

14 August 2017

1 reference

title

Emerging pharmacological strategies in the fight against cocaine addiction (English)

1 reference

14 August 2017

Mehmet Sofuoglu

1

1 reference

PubMed ID

16503828

14 August 2017

Thomas R Kosten

series ordinal

2

1 reference

PubMed ID

16503828

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Expert Opinion on Emerging Drugs

14 August 2017

1 reference

14 August 2017

11

1 reference

14 August 2017

1

1 reference

14 August 2017

91-98

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

14 August 2017

1 reference

Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Route of cocaine administration: patterns of use and problems among a Brazilian sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Injecting and non-injecting cocaine use in Sydney, Australia: physical and psychological morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Comparing i.v. and non-i.v. cocaine users. Characteristics of a sample of cocaine users seeking to participate in research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Cocaine medications, cocaine consumption and societal costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Psychosocial treatments for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Incentives improve outcome in outpatient behavioral treatment of cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Current developments in psychosocial treatments of alcohol and substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Recent advances in the dissemination of contingency management techniques: clinical and research perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Evidence-based practices for substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Neural mechanisms of drug reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Opponent process model and psychostimulant addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

A potential role for GABA(B) agonists in the treatment of psychostimulant addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

A novel strategy for the treatment of cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Role of the hypothalamic-pituitary-adrenal axis in reinstatement of cocaine-seeking behavior in squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

The effect of cannabinoid receptor antagonism with SR141716A on antinociception induced by cocaine and the NMDA receptor antagonist, MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Carbamoylation of brain glutamate receptors by a disulfiram metabolite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Disulfiram effects on acute cocaine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Effects of amantadine on uptake and release of dopamine by a particulate fraction of rat basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Anticholinergic and membrane activities of amantadine in neuromuscular transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

A pilot trial of topiramate for the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

The GABA transporter and its inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Pharmacology and clinical experience with tiagabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Effects of labetalol treatment on the physiological and subjective response to smoked cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Carvedilol affects the physiological and behavioral response to smoked cocaine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

An evaluation of the abuse potential of modafinil using methylphenidate as a reference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Acute behavioral and physiological effects of modafinil in drug abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Modafinil elicits sympathomedullary activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

A double-blind, placebo-controlled trial of modafinil for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Replacement medication for cocaine dependence: methylphenidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Human therapeutic cocaine vaccine: safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Vaccine pharmacotherapy for the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Effects of drugs on food- and cocaine-maintained responding, III: Dopaminergic antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Comorbid Major Depressive Disorder as a Prognostic Factor in Cocaine‐Abusing Buprenorphine‐Maintained Patients Treated with Desipramine and Contingency Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Pharmacological treatment of cocaine dependence: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

Pharmacologic Interventions for Alcohol- and Cocaine-Abusing Individuals: A Pilot Study of Disulfiram vs. Naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.1.91

21 January 2018

Identifiers

DOI

10.1517/14728214.11.1.91

1 reference

14 August 2017

1 reference

PubMed ID

16503828